NCT00003108View on ClinicalTrials.gov

Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1997

Study Completion Date

October 31, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bryostatin 1

DRUG

cisplatin

Trial Locations (1)

20007

Lombardi Cancer Center, Washington D.C.

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Lombardi Comprehensive Cancer Center

OTHER

NCT00003108 - Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter